Epitope regions in the heavy chain of Clostridium botulinum type E neurotoxin recognized by monoclonal antibodies

Applied and Environmental Microbiology

Volumn 63, Issue 4, 1997, Pages 1214-1218

  Kubota, Toru ^a   Watanabe, Toshihiro ^b   Yokosawa, Noriko ^a   Tsuzuki, Kayo ^a   Indoh, Tomokazu ^a   Moriishi, Kohji ^d   Sanda, Kenji ^c   Maki, Yoshiyuki ^c   Inoue, Katuhiro ^b   Fujii, Nobuhiro ^a,e  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^c Science TANAKA   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLOSTRIDIUM BOTULINUM; NONHUMAN; PROTEIN DOMAIN;

CLOSTRIDIUM BOTULINUM;

EID: 0031002640     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.63.4.1214-1218.1997     Document Type: Article

References (19)

1. Binz, T., J. Blasi, S. Yamasaki, A. Baumeister, E. Link, T. C. Sudhof, R. Jahn, and H. Niemann. 1994. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. Biol. Chem. 269:1617-1620.
2. Blasi, J., E. R. Chapman, S. Yamasaki, T. Binz, H. Niemann, and R. Jahn. 1993. Botulinum neurotoxin C1 blocks neurotransmiter release by means of cleaving HPC/syntaxin. EMBO J. 12:4821-4828.
3. Cleveland, D. W., S. G. Fischer, M. W. Kirschner, and U. K. Laemmli. 1977. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel eloctrophoresis. J. Biol. Chem. 252:1102-1106.
4. Frank, R. 1992. Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 48:9217-9232.
5. Fujii, N., K. Kimura, T. Murakami, T. Indoh, T. Yashiki, K. Tsuzuki, N. Yokosawa, and K. Oguma. 1990. The nucleotide and deduced amino acid sequences of EcoRI fragment containing the 5′-terminal region of Clostridium botulinum type E toxin gene cloned from Mashike, Iwanai and Otaru strains. Microbiol. Immunol. 34:1041-1047.
6. Fujii, N., K. Kimura, T. Yashiki, T. Indoh, T. Murakami, K. Tsuzuki, N. Yokosawa, and K. Oguma. 1991. Cloning of a DNA fragment encoding the 5′-terminus of botulinum type E toxin gene from Clostridium butyricum strain BL6340. J. Gen. Microbiol. 137:519-525.
7. Fujii, N., K. Kimura, T. Yashiki, K. Tsuzuki, K. Moriishi, N. Yokosawa, B. Syuto, and K. Oguma. 1992. Cloning and whole nucleotide sequence of the gene for the light chain component of botulinum type E toxin from Clostridium butyricum strain BL6340 and Clostridium botulinum type E strain Mashike. Microbiol. Immunol. 36:213-220.
8. Hirano, H., and T. Watanabe. 1990. Microsequencing of proteins electrotransferred onto immobilizing matrices from polyacrylamide gel electrophoresis: application to an insoluble protein. Electrophoresis 11:573-580.
9. Kamata, Y., Y. Kimura, T. Hiroi, G. Sakaguchi, and S. Kozaki. 1993. Purification and characterization of the ganglioside-binding fragment of Clostridium botulinum type E neurotoxin. Biochim. Biophys. Acta 1156:213-218.
10. Kimura, K., N. Fujii, K. Tsuzuki, N. Yokosawa, and K. Oguma. 1992. The functional domains of Clostridium botulinum type C neurotoxin, p. 375-385. In P. Gopalakrishnakone and C. K. Tan (ed.), Recent advances in toxinology research. Venom and toxin research group, National University of Singapore, Singapore.
11. Kozaki, S., J. Onimaru, Y. Kamata, and G. Sakaguchi. 1991. Immunological characterization of Clostridium bitiyricum neurotoxin and its trypsin-induced fragment by use of monoclonal antibodies against Clostridium botulinum type E neurotoxin. Infect. Immun. 59:457-459.
12. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
13. Maisey, E. A., J. D. Wadsworth, B. Poulain, C. C. Shone, J. Melling, P. Gibbs, L. Tauc, and J. O. Dolly. 1988. Involvement of the constituent chains of botulinum neurotoxin A and B in the blockade of neurotransmitter release. Eur. J. Biochem. 177:638-691.
14. Montal, M. S., R. Blewitt, J. M. Tomich, and M. Montal. 1992. Identification of an ion channel-forming motif in the primary structure of tetanus and botulinum neurotoxin. FEBS Lett. 313:12-18.
15. Schiavo, G., F. Benfenati, B. Poulain, O. Rossetto, D. L. P. Polverino, B. R. DasGupta, and C. Montecucco. 1992. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin [see comments]. Nature 359:832-835.
16. Schiavo, G., C. C. Shone, O. Rossetto, F. C. Alexxander, and C. Montecucco. 1993. Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J. Biol. Chem. 268:11516-11519.
17. Tsuzuki, K., N. Yokosawa, B. Syuto, I. Ohishi, N. Fujii, K. Kimura, and K. Oguma. 1988. Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D and E toxins and tetanus toxin. Infect. Immun. 56:898-902.
18. Yamasaki, S., T. Binz, T. Hayashi, E. Szabo, N. Yamasaki, M. Eklund, R. Jahn, and H. Niemann. 1994. Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2. Biochem. Biophys. Res. Commun. 200:829-835.
19. Yokosawa, N., K. Tsuzuki, B. Syuto, and K. Oguma. 1986. Activation of Clostridium botulinum type E purified by two different procedures. J. Gen. Microbiol. 132:1981-1988.